Let's assume that all the promise comes to fruition, that Apabetalone becomes Standard of Care for Diabetics, and CKD patients on Dialysis, those suffering from Alzheimers and Thrombosis as well as oprham diseases like Fabry's, Friedrich's Ataxia and at least one Musclular Dystrophy condition....

In other words it becomes a minimum $10 billion USD drug....and if it does end up treating all those conditions I don't think that's unrealistic....and likely undervalued.  

What's RVX's MC right now?  Not even a piddly $200 million CDN.  And how many shares are in the hands of dumb money retail sheep?  No way to know for sure, except that its less than 50 million....so just to give it a number, lets say its $10 million shares....10 million shares that are right now worth less than $150 million CND.   10 million shares, that if Apabetalone does everything it shows promise to do.....who knows how much dilution might come into play if everything comes up roses, but obvioulsy there would be some.   Let's say RVX will one day be trading for $50 per share or more.....that would mean those 10 million shares would be worth $500,000,000.00.....that's a massive jump obviously.

Am I dreaming with technicolour glasses?  Yeah....probably.  But if it does play out and retailers are holding 10 or 20 million of the 50 odd million in the public float.....